摘要 |
The present invention is directed to a bicyclic heteroaryl benzamide compounds of formula (I) which are tropomyosin-related kinase (Trk) family protein kinase inhibitors, and hence are useful in the treatment of pain, inflammation, cancer, restenosis, atherosclerosis, psoriasis, thrombosis, a disease, disorder, injury, or malfunction relating to dysmyelination or demyelination or a disease or disorder associated with abnormal activities of nerve growth factor (NGF) receptor TrkA. |
申请人 |
Merck Sharp & Dohme Corp. |
发明人 |
MITCHELL, Helen;WOOD, Harold, B.;LI, Chun, Sing;MAO, Qinghua;QI, Zhiqi |